To determine if physician specialty is associated with underutilization and underdosing of angiotensin-converting enzyme inhibitors among patients with heart failure, we reviewed the charts of 214 outpatients with decreased systolic function at an urban academic medical center. Regardless of whether patients were cared for by cardiologists, generalist physicians, or a combination of the two specialties, approximately 75% of the patients were taking an angiotensinconverting enzyme inhibitor. However, only approxinmtely 60% of these patients were taking dosages proved to be efficacious in trials. Emphasis on adequate dosing is needed among all specialty groups. WORDS: angiotensin-converting enzyme {ACE) inhibitor; congestive heart failure; physician behavior; specialty; quality of care.
Little is known, however, about the factors associated with underutilization and underdosing, 4,'" Some studies suggest that cardiologists are more likely than generalist physicians to prescribe ACE inhibitors in circumstances and dosages that accord with established guidelines, r,'~,l:,ls However. these latter studies are limited because they either were surveys of physicians' knowledge, or else did not limit their population to patients with decreased systolic function. Therefore, to determine if physician specialty and patient characteristics are associated with underutiliza tion and underdosing of ACE inhibitors, we performed a cross sectional study of outpatients with heart failure.
METHODS

Study Population
We retrospectively identified all patients seen at the University of Chicago's cardiology, general internal medicine, and geriatrics clinics between January 1, 1994, and June 30, 1996, who received an outpatient billing diagnosis of International Classification of Diseases code 428 (congestive heart failure) or 425.4 (cardiomyopathy). 14 We reviewed the medical records of these patients, and then selected those patients with moderately or severely decreased systolic function (fractional shortening 18% to 24% and less than 18o/o. respectively), determined primarily through echocardiogram, and rarely through cardiac catheterization or nuclear scan. We divided the patients into three groups: (1) patients seen by a cardiologist, but not by a general internist or geriatrician, as determined through both the administrative computer system and review of the medical record: (2) patients seen by either a general internist or geriatrician. but not by a cardiologist: and (3) patients seen by a cardiologist and either a general internist or a geriatrician.
Data Collection
We obtained the history, eomorbid conditions, and most recent vital signs, laboratory values, and medications from the medical record. We extracted demographic 563 and insurance data from the administrative billing sys tem. We measured comorbid illnesses with the Charlson Comorbidity Index. is
Statistical Analysis
We compared patients from the different groups us ing the X: test for categorical variables, mid Student's t test or the Wilcoxon test for continuous variables, We defined an adequate ACE inhibitor dose as that proved to be efficacious in the large randomized, controlled trials of these medications (captopril. 50 mg tid: enalapril. 10 mg bid: lisinopril, 10 rng qd: ramipril, 5 rng bid). is For the 20 patients (12%) on a different ACE inhibitor, we used the following criteria: benazepriL 20 mg qd: fosinopriL 20 mg qd: and quinapril, 10 rng bid, all taken orally. Dosage of ACE inhibitors was analyzed with both a binary variable of adequate or not. and a continuous variable calculated as the percentage of an adequate dose a patient received. For example, given that an oral dosage of captopril of 50 mg tid has been demonstrated to reduce mortality. 3 a 25-mg dose on the same schedule was considered to be "not ade quate" as it was only 50% of the adequate dose, Assuming that 85% of cardiologists would choose an ACE inhibitor for their patients with moderately or severely reduced sys tolic function, we have 80% power to detect an absolute difference of 25 percentage points in utilization of these medications by cardiologists and generalist physicians at a significance level ofp ,05. two-tailed, By chart review, three patients were unable to tolerate an ACE inhibitor. They were subsequently excluded from drug analyses except for when use of either an ACE inhibitor or the hydralazine/nitrate combination was the end point. We used multivariable logistic and linear re gression to determine independent correlates of the utilization and dosing of ACE inhibitors (enter atp -< .10. stay at p < .05, two tailed). In the dosing analyses, we automati cally adjusted for hypertension, coronary artery disease, and whether systolic blood pressure was less thin1 110 rnm Hg, We also performed a subgroup analysis that excluded pa tients in whom the use of ACE inhibitors could be more complicated, namely, when creatinine level was above 3.0 rng/dL, potassium level was above 5.5 mmol/L, and systolic blood pressure was less than 100 nml Hg, 12,1S
RESU LTS Study Sample and Patient Characteristics
We identified 647 outpatients with a diagnostic code of congestive heart failure or cardiomyopathy. For these, we retrieved 493 (760/0) of the charts, Measurements of left ventricular function were available on 419 (85%) of these patients, and 214 (51%) had moderately or severely re duced systolic function. Patients of generalist physicians were older than those of cardiologists, and they were more likely to be African American and to have a history of hy pertension (Table 11 .
Utilization and Dosing of Angiotensin-Converting Enzyme Inhibitors
Similar percentages of patients cared for by cardiolo gists, generalist physicians, and the combination of the two were prescribed ACE inhibitors ( Table 2 ). Rates of usage of ACE inhibitors were approximately 75%. However, among patients taking these medications, only 540/o to 70o/0 were on dosages proved to be efficacious in clinical trials. Of the three most commonly prescribed medications, dos age was adequate least frequently (p < .05) with captopril (46%) and enalapril (580/o). than with lisinopril (82%), (6 35%) . and patients of generalist physicians (l~ = 58%) received higher doses of ACE inhibitors (p -< ,05), However. the latter model explained only 13% of the variance in dose, In subanalyses excluding patients with creatinine level above 3,0 mg/dL, potassium level above 5,5 nmlol/L, and systolic blood pressure less than 100 rnm Hg. the results were similar.
Independent Correlates of Utilization and Dosing
DISCUSSION
Regardless of physician specialty, most patients with decreased systolic function were prescribed an ACE in hibitor, but only about 60% were on dosages proved to be efficacious in controlled trials. No trends favoring special ist or combined specialist generalist care were apparent: in fact. generalist physicians prescribed higher doses, We suspect that generalist physicians prescribed higher dos ages than cardiologists because their patients were more likely to have hypertension, a factor that our regression analyses may have been unable to adjust for fully.
In comparison, a national survey using clinical vignettes found that generalist physicians were less likely than cardiologists to prescribe ACE inhibitors among asymptomatic patients with decreased systolic function. and they were also less likely to use dosage as an end point for titrating these medications. ' -~ Studies of outpa 
